60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $438 | $101 | $164 | $261 |
| % Growth | 333.6% | -38.3% | -37.4% | – |
| Cost of Goods Sold | $538 | $50 | $73 | $118 |
| Gross Profit | -$100 | $51 | $90 | $143 |
| % Margin | -22.9% | 50.4% | 55.2% | 54.8% |
| R&D Expenses | $810 | $250 | $408 | $614 |
| G&A Expenses | $1,507 | $1,613 | $1,686 | $0 |
| SG&A Expenses | $1,507 | $1,613 | $1,686 | $1,605 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$91 | -$207 | -$93 | $0 |
| Operating Expenses | $2,225 | $1,656 | $2,001 | $2,219 |
| Operating Income | -$2,326 | -$1,605 | -$1,911 | -$2,076 |
| % Margin | -531.4% | -1,590% | -1,168.4% | -794% |
| Other Income/Exp. Net | $9 | -$129 | $34 | $26 |
| Pre-Tax Income | -$2,317 | -$1,733 | -$1,877 | -$2,049 |
| Tax Expense | $0 | $2 | $0 | -$1 |
| Net Income | -$2,317 | -$1,734 | -$1,877 | -$2,049 |
| % Margin | -529.5% | -1,717.7% | -1,147.4% | -783.6% |
| EPS | -0.66 | -1.25 | -1.56 | -4.5 |
| % Growth | 47.2% | 19.9% | 65.3% | – |
| EPS Diluted | -0.66 | -1.25 | -1.56 | -4.5 |
| Weighted Avg Shares Out | 3,675 | 1,473 | 1,283 | 455 |
| Weighted Avg Shares Out Dil | 3,675 | 1,473 | 1,283 | 455 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $2 | $1 |
| Depreciation & Amortization | $23 | $20 | $17 | $16 |
| EBITDA | -$2,292 | -$1,713 | -$1,859 | -$2,032 |
| % Margin | -523.8% | -1,696.7% | -1,136.4% | -777.3% |